PURPOSE: To understand the factors that influence glaucoma treatment adherence with medication taking, prescription refills, and appointment keeping to develop an intervention for a specific population. PATIENTS AND METHODS: In-depth interviews were conducted with 80 individuals diagnosed with open-angle glaucoma, glaucoma suspect, or ocular hypertension. Additional eligibility requirements were that all participants were: between the ages of 18 to 80; white or African American; spoke and understood English; and were taking daily doses of topical glaucoma treatments for at least the past year. Cross-tabulations and chi2 tests were conducted to compare adherent and nonadherent individuals, classified as such based on self-report and medical chart/pharmacy data. RESULTS: Compared with adherent participants, nonadherent participants were less likely to: believe their eye doctors spent sufficient time with them; ask their eye doctor if they had any questions; know of benefits to taking their glaucoma medication regularly; and have someone help them take their glaucoma medications or drive them to eye appointments. Conversely, compared with adherent individuals, nonadherent participants were more likely to have difficulty remembering to take their medications and to believe their glaucoma would affect their eye sight in the future. CONCLUSIONS: Nonadherent glaucoma patients struggle with a variety of issues related to consistent use of glaucoma medicine and routine eye care. Interventions are needed to address these modifiable factors related to glaucoma treatment adherence.
PURPOSE: To understand the factors that influence glaucoma treatment adherence with medication taking, prescription refills, and appointment keeping to develop an intervention for a specific population. PATIENTS AND METHODS: In-depth interviews were conducted with 80 individuals diagnosed with open-angle glaucoma, glaucoma suspect, or ocular hypertension. Additional eligibility requirements were that all participants were: between the ages of 18 to 80; white or African American; spoke and understood English; and were taking daily doses of topical glaucoma treatments for at least the past year. Cross-tabulations and chi2 tests were conducted to compare adherent and nonadherent individuals, classified as such based on self-report and medical chart/pharmacy data. RESULTS: Compared with adherent participants, nonadherent participants were less likely to: believe their eye doctors spent sufficient time with them; ask their eye doctor if they had any questions; know of benefits to taking their glaucoma medication regularly; and have someone help them take their glaucoma medications or drive them to eye appointments. Conversely, compared with adherent individuals, nonadherent participants were more likely to have difficulty remembering to take their medications and to believe their glaucoma would affect their eye sight in the future. CONCLUSIONS: Nonadherent glaucomapatients struggle with a variety of issues related to consistent use of glaucoma medicine and routine eye care. Interventions are needed to address these modifiable factors related to glaucoma treatment adherence.
Authors: Michael A Kass; Dale K Heuer; Eve J Higginbotham; Chris A Johnson; John L Keltner; J Philip Miller; Richard K Parrish; M Roy Wilson; Mae O Gordon Journal: Arch Ophthalmol Date: 2002-06
Authors: Brenda L Plassman; Kenneth M Langa; Gwenith G Fisher; Steven G Heeringa; David R Weir; Mary Beth Ofstedal; James R Burke; Michael D Hurd; Guy G Potter; Willard L Rodgers; David C Steffens; John J McArdle; Robert J Willis; Robert B Wallace Journal: Ann Intern Med Date: 2008-03-18 Impact factor: 25.391
Authors: Lyne Racette; M Roy Wilson; Linda M Zangwill; Robert N Weinreb; Pamela A Sample Journal: Surv Ophthalmol Date: 2003 May-Jun Impact factor: 6.048
Authors: Rohit Varma; Mei Ying-Lai; Brian A Francis; Betsy Bao-Thu Nguyen; Jennifer Deneen; M Roy Wilson; Stanley P Azen Journal: Ophthalmology Date: 2004-08 Impact factor: 12.079
Authors: Karen Glanz; Allen D Beck; Lucja Bundy; Susan Primo; Michael J Lynn; Julia Cleveland; Jessica A Wold; Katharina V Echt Journal: Arch Ophthalmol Date: 2012-10
Authors: Man-Hin Lui; Jason Chun Ho Lam; Yi Lee Kwong; Tak Siu Wong; Pak Long Cheung; Sherri Shun Yan Lai; Pak Lun Yuen; Wai Yiu Lam; Ho Yan Chan; Yiu Fai Wong; Jimmy Shiu Ming Lai; Kendrick Co Shih Journal: Int J Ophthalmol Date: 2017-02-18 Impact factor: 1.779
Authors: Paula A Newman-Casey; John A Musser; Leslie M Niziol; Michele M Heisler; Shivani S Kamat; Manjool M Shah; Nish Patel; Amy M Cohn Journal: J Glaucoma Date: 2019-05 Impact factor: 2.503
Authors: Paula Anne Newman-Casey; Alan L Robin; Taylor Blachley; Karen Farris; Michele Heisler; Ken Resnicow; Paul P Lee Journal: Ophthalmology Date: 2015-04-24 Impact factor: 12.079
Authors: Paula Anne Newman-Casey; Sathya Ravilla; Aravind Haripriya; Vinoth Palanichamy; Manju Pillai; Vijayakumar Balakrishnan; Alan L Robin Journal: Ophthalmic Epidemiol Date: 2015 Impact factor: 1.648
Authors: Delesha M Carpenter; Gail E Tudor; Robyn Sayner; Kelly W Muir; Alan L Robin; Susan J Blalock; Mary Elizabeth Hartnett; Annette L Giangiacomo; Betsy L Sleath Journal: Patient Educ Couns Date: 2015-07-06